In the first of this two-part podcast series, gastroenterologist Dr Mohid Khan and NET patient advocate Sally Jenkins explore the patient and physician perspectives of shared decision-making and how both parties can contribute to optimising consultations.

 

In the second of this two-part podcast series, gastroenterologist Dr Mohid Khan and NET patient advocate Sally Jenkins explore NET shared decision-making in the context of individualising treatment decisions.

 

Listen and follow our podcasts on:

Ipsen

In this discussion, the experts draw on their own experiences, giving an insight into best practices and key considerations. Conversation topics include:

  • The importance of communication and collaboration during consultations
  • Practical tips on how to make a patient feel as comfortable and in control as possible
  • What makes a good consultation, from the perspectives of both a patient and a physician
  • The importance of support networks, individualising treatment, and the impact of NET and NET treatment options in daily life

 

Clinical takeaways

  • Considering patient perspectives enables patients with NETs to feel listened to, more relaxed, and in control
  • Shared decision-making in NET management allows for tailored consultations based on individual patient preferences and needs
  • Evidence suggests that patients with NETs prefer treatment injections at home to hospital visits

Educational objectives

  • Highlight the value of shared decision-making in NET management

NET Shared Decision-Making  

Optimising physician and patient consultations 

Episode 1: Patient Journey 

 

 

Brought to you by 

Dr Mohid S Khan, Consultant in Gastroenterology & NETs, Clinical Lead, South Wales NET Service, University Hospital of Wales 

Sally Jenkins, NET Patient and Patient Advocate 

 

Please note: 

NET CONNECT podcasts are designed to be listened to. If possible, we encourage you to listen to the audio or watch the video, which includes emotion and emphasis that cannot be portrayed in the transcript. Transcripts are edited for readability. Please check the corresponding audio before quoting in print. 

 

This podcast is supported by an independent educational grant from Ipsen.  

 

Dr Mohid Khan 

Welcome to our podcast, where we're going to talk about shared decision-making in neuroendocrine tumours, or NETs, how to individualise patient treatment and factors associated with that. I’m Dr Mohid Khan. I'm a Consultant Gastroenterologist and lead at the Neuroendocrine Tumour Service, South Wales, UK, and this is Sally. 

 

Sally Jenkins 

Hello, I'm Sally Jenkins. I'm a NET patient of 15 years standing, and learned to live with it. It's changed my normality, but I now have a different one. And over the years, I've been quite involved with patient support, patient groups and also advocacy.  

 

Dr Mohid Khan 

Tell me about your experience from the start.  

 

Sally Jenkins 

Right. Goes back 15 years. I was diagnosed in 2009, but before that, for a couple of years, I'd been having increasingly severe symptoms, but they were rather nonspecific. So it was mainly pain, abdominal pain, diarrhoea, feelings of tiredness and a very slow weight loss. But it was, as I say, very nonspecific. So I was one of those patients that was in and out of the GP surgery, one of the ‘revolving door’ type of patients, and I went through all sorts of tests, none of which actually showed anything. And so I was beginning to wonder whether I was actually making it all up, or whether I’d turned into a middle-aged well-woman who was inventing all these different symptoms. But then, just at the end of 2008 I thought, I'm going to do something serious about this, and early in 2009 I had a private CT scan and something showed up there.  

 

But before anything could be done, I actually saw a surgeon and I was scheduled for routine surgery, but before anything could be done nature took over, and the NETs turned ischaemic, in other words, they blocked a blood vessel in my abdomen, and I became really ill. So I was blue-lighted into a local hospital and had emergency surgery. So I was in hospital for a couple of months and when I came out, I was minus quite a large amount of small bowel, also minus some large bowel, I had a stoma and I was being fed through a tube that went in through the chest. 

 

So I went home for seven months and then I was one of the fortunate ones that could have the surgery reversed. So I lost the stoma, but for a short while it was touch-and-go whether I still had enough digestive system left to actually survive without artificial feeding. Again, I was one of the lucky ones. I can survive just eating ordinarily, even though I do have quite a lot of restrictions about what I can eat. 

 

But that was not the end of the story. Although I was medically stable and I was given injections to stop the NETs that were still left, because there were a lot that were inoperable and were still there, I was given injections to stop them progressing. But, my condition was not particularly well managed because I didn't really have access to specific NET expertise at that time. 

 

So, I still had very similar symptoms to before diagnosis, and that was getting abdominal pain and that was necessitating admission into hospital, I still had a lot of diarrhoea, and I was still tired. But then, after a couple of years, I was very fortunate, I did gain access to NET expertise. And when that happened, my life just changed completely because the condition was managed correctly. And so that took about a year to sort out, including having something called an ERCP, which is a fancy type of gastroscope, which solved the abdominal pain problems, because what had been happening was that it was assumed that these pains were to do with my condition, and in fact they weren’t, it was something completely different. So it took a NET specialist thinking outside the box to actually sort everything out. Then after those couple of years, there was still no specialist NET service in my area, so I was referred out to a Centre of Excellence. And things continued very stable for years, which was really great. I couldn't go back to a normal life, I never have done, but I could establish a new normality. 

 

So things stayed stable for about ten years and then the NET started moving again. Started growing. Now that is not a disaster because there's something called PRRT, which is a nuclear therapy. I had that. It needed four doses, three months apart, over the period of a year. And that happened during lockdown and I have to hand it to the NHS, lockdown did not stop them. It just kept carrying on as if nothing was happening. So it didn't affect my treatment at all. Even though I was having to go up to London to have it done, and I was mildly radioactive after each dose, but it did what it said on the tin. It stabilised the tumours and they have stayed stable since then. That was in 2020.  

I forgot to mention, between the time when I was transferred to the Centre of Excellence and the PRRT, I was so stable that I was able to have things like a hip operation. I had a hip replacement. So, life can continue very much normally, even with a quite severe cancer. 

 

Dr Mohid Khan 

Thank you Sally. That’s a summary of a very long, long story. Throughout that story, you've had lots of consultations, various notes, so what makes a good consultation?  

 

Sally Jenkins 

It's if the person on the other side of the table is listening to you, that is really the main thing, and also has the expertise that is necessary. Because in the beginning, before I actually got in touch with anybody that had NET expertise, I was told I was treated by very competent people, but they weren't specialists. And so sometimes I would go into the room and the doctor would actually say to me things like, “Well I'm not sure of the details of your cancer. Can you tell me what you know?” Now, that's not what you want to hear from a specialist, because for the previous couple of months you will have been thinking, oh, I wonder what this is? I wonder what that is? And you store all those questions and when you get to the expert, you want the expert to actually have comprehensive knowledge. So, if they try and blag it, you can really suss that out pretty quickly. If you know that that person has a certain amount of knowledge but is willing to admit that they don't know everything and that they will find it out for you, then your confidence increases, and you know then that they're listening to you and that they have the knowledge to be able to treat you competently. 

 

Dr Mohid Khan 

So, that knowledge and expertise instils a confidence as a patient?   

 

Sally Jenkins 

Yes. Yes it does.  

 

Dr Mohid Khan 

Are there any other factors that made you think, oh, that was a good consultation or a bad consultation?  

 

Sally Jenkins  

I think when you walk through the door, in the first 30 seconds, you establish whether or not it's going to be good and it's all to do, I think, with body language. If your doctor is looking at you and has your attention, you are, you know, his focus or her focus. 

 

Dr Mohid Khan 

Rather than looking at the computer? 

 

Sally Jenkins  

Yes, rather than looking at the computer or whatever. Treats you as a human being. A smile always helps, even if they've got the cares of the world on their shoulders, a smile for you is actually quite important because, even though patients appear confident, and I've met hundreds of NET patients now in various meetings and support groups, underneath it all, we are nervous. We may not show it and we may not say it, but we are quite worried even if it's buried very deep. So if when you walk through the door, you think, oh yes, this person is on my side and is going to listen to me. Then that sets everything off to a good start, and that is down to expression and body language.  

 

Dr Mohid Khan 

So communication skills, and then, as I said, probably from the clinician’s perspective, communication skills are being taught nowadays at medical school to varying degrees throughout the world. And, you know, I've always thought that communication skills and how you make the patient feel is really important. So from my perspective as a clinician, obviously the consultation, there's a goal to the consultation which is relaying information or answering questions, there’s all sorts of different types of consultation and also different types of patients and people, you know, I'm a patient and I have quite a lot of different types of consultation myself, and everyone's different I think. And one person is different to another person and it's a range of personalities throughout society that are represented, and I probably found that difficult initially years and years ago. But I think something for clinicians, which I've learned over years, is trying to be adaptable to the patient. So some patients come to me and go, ‘oh, so just tell me how it is or tell me what to do’. But then some people want to be really involved and the goals of the consultation, I think, are quite important. From a patient perspective, how do you feel about setting out goals at the beginning of a consultation?   

 

Sally Jenkins 

I find that really useful. Yes. The consultations that I've been through have changed over the years because in the beginning, it's novelty and, you know, you want lots of information quickly and I always found that I wanted to be told what to do because I thought, you know, the experts know what they're doing. I just need that. As I've gone on, now that I've got more expertise myself, I want information, but sometimes I need it spread out in a slightly different way. But it's always useful at the beginning to know that you've got common goals. And so, you know, saying, ‘well, in this consultation we're going to discuss this and this. Are you happy with that?’ to the patient is reassuring and it also gives you something at the end that you can review and go over and say, ‘oh yes, we’ll come to this decision and that decision, and that decision’. And that will sometimes spark another question, because something that we do an awful lot of, and I've done it myself even after 15 years, is I have this total blank halfway through. I've got a whole list of questions. They are written down on a piece of paper. I practise them before, but I'll still leave them out and so sometimes that reviewing of the goals will spark a question that otherwise could have been left out.  

 

Dr Mohid Khan 

I think that's important. I felt that as a patient myself, I will often leave the consultation and have forgotten, ‘oh I wish I'd asked that’. So, I have then over the years thought about that in consultations with patients. At the end I'll offer a chance to them, “Have you understood everything, are you happy with this plan? Have you got any questions to ask?” But then knowing if they think about it and they're not sure when they're thinking I'll actually use the computer and, sort of, request some things whilst it gives them a little chance to think about questions and also offer them afterwards at the end saying, “Well, if you have any questions afterwards, we have a nurse specialist. So there's an opportunity at some point in the future to ask those questions”.  

 

Sally Jenkins 

That's really good because what it does, it takes the pressure off and when you're more relaxed, then you do remember things. But that little thing that you just said of, turning away and maybe writing something on the computer, it gives you just that little chance to feel relaxed and comfortable, to think, ‘oh yes, that last question that came up’. 

The other thing that is useful and, you know, you see it on an awful lot of websites and discussion things, is write your questions down before you go. Don't be afraid to get a pen and paper out and show them, you know, go down and say, “Would you mind if I asked you these questions?” Write down answers. But also, if you have somebody with you who is also briefed, and can prompt, you know, somebody that you're comfortable with, and if the clinician welcomes them as well and includes them, then that all adds to the atmosphere of being relaxed, because being relaxed and confident I think is the key. 

 

Dr Mohid Khan 

Yes, I completely agree with you. And what we want is the patients and the relatives or friends or carers to be comfortable enough to ask those questions at the end. And quite often people will have a list of questions, and they'll bring that out at the end. And I guess, I asked about what makes a good consultation, quite a lot of the time, if they bring out a list of questions at the end and they've gone through to the end and actually going, ‘oh, well, actually you've covered everything’, then I think at least I've enabled a good consultation or a relaxed consultation so that there's enough information that they can go away and feel that they've got confidence in us and the whole service.  

 

Sally Jenkins 

Yes. Also having the option to ring back later, that’s really important to, you know, to get back to a CNS (Clinical Nurse Specialist) and you know that the CNS will also have access then to the clinician. So if you’ve really forgotten something you can always go back. 

 

Dr Mohid Khan 

So, shared decision-making and individualised preferences, what would be your goals? What's the most important, sort of, points and goals and preferences in shared decision-making, from a patient perspective? 

Sally Jenkins 

I think from the patient point of view, it's all to do with a feeling of control. As we've said earlier, sometimes patients do want to be told what to do, but even those who think they need instruction do like to have a little bit of choice. And I think, with NETs, there are so many different pathways. Different patients have different pathways, but then there are options even for one particular patient, I think I’m right there, aren’t I?  

 

Dr Mohid Khan 

Yes. I mean, sometimes there's no right or wrong answer, which is what I tell quite a few patients.  

 

Sally Jenkins 

It's just a balance of probabilities that that one might work a bit better than that one, or doing nothing might be okay.  

 

Dr Mohid Khan 

Yes. I mean, we've got multi-disciplinary team meetings where there's a lot of specialists involved in neuroendocrine tumours, who will have a consensus, where then it's the senior responsible clinician’s duty to involve the patient in the discussion during consultation. And really, I think it's up to the clinician to offer those options and say, ‘well there are alternatives but this is the preferred option’. And sometimes it's also relying on the fact there's no certainty and weighing up pros and cons of each. And as you said, in some patients, if you have different patients and they've got the same type of NET and the same sort of stage, etc. There are other factors involved that the patient might bring to the table to influence what the best shared-decision is.  

For example, I assume, I mean, there are patients that have their lives affected, I mean, everyone's life is affected by neuroendocrine tumours, and the people around them, there's work and family, travel involved, which decisions can affect. I mean have you had that experience yourself?  

 

Sally Jenkins  

Yes, I have, gosh, it had a huge effect on my family. Well, when I was diagnosed, I was a wife, mother, had a daughter at university and was a lecturer. I had a very busy life. That all disappeared, and it affected the whole family around me and all my colleagues. And so the timing of some treatments made a lot of difference. You know, I was a lecturer, so life during the summer wasn't as pressured as during term time and if you can fit choices in around that, it makes a huge, huge difference.  

The other thing that I've noticed as well, not so much with me, but a few of my fellow patients have mentioned it, is travel and particularly controlling symptoms, because it's very difficult to travel if you have to be in the loo every half hour. Now, just the simple thing of getting the balance of medication right and having the choice to do that can make a lot of difference. And even being told things like, “Well, have you heard of the radar key scheme?” You know, that made a huge difference to a fellow patient. Before, they weren’t going on holiday. But when they heard about that, they said, “Yep, we'll go”, because of confidence. It was a matter of confidence. But all those little things that you can adjust slightly and they will turn into a viable life. Whereas if they're not adjusted then you haven't got a viable life and that is really important to the patient.  

 

Dr Mohid Khan 

So there are life-changing factors involved in shared decision-making? And I guess you were referring to the radar key, which is in the United Kingdom, which allows you access to toilets that are locked in public places. So, yes. So that's a sort of a preference-influencing factor, in shared decision-making. Are there any other, sort of, goals and preferences that you think yourself or patients may have which would affect shared decision-making? I mean, I guess from my perspective, I know that people are different and as you say, some people just want a doctor or clinician just to make a decision because they don't, maybe, either understand the information even if it's relayed in a very simple way, or are used to someone just making the decision for them. Whereas some people want to get very, very involved, and want all the information and judging how much information someone wants before making that decision together or delegate that decision is really important.  

 

Sally Jenkins  

That's something that I've always admired doctors for, because you have to sum up quite quickly how much information a patient needs, and giving them too much will frighten the living daylights out of some. But you got to do that almost instantaneously, and that must be quite difficult to do. I've always admired that because it's such a close call, but it makes an awful lot of difference to a person. And, you know, some people want to know whether in a particular test, the number was 58 or 57, and to them it makes a huge amount of difference. Where others will just want to know, ‘okay, it's in the normal range’ and they're happy with that. And you've actually got to judge that and get that across.  

 

Dr Mohid Khan 

It is a difficult skill, which, I have to check in at the beginning of the consultation just to see… 

 

Sally Jenkins  

Yes, so how do you do that?  

 

Dr Mohid Khan 

I mean, I think it's just the… I think it comes with experience and setting the goals right at the beginning of the consultation, that introduction thing we talked about earlier, and making people feel relaxed, then I think it's a human-factor skill, being able to judge … We ask people but sometimes, you know, people are anxious and worried and there's always opportunities afterwards to get more information, as you say, because ultimately, if we get to the point of shared decision making, if someone, someone legally in England and Wales, for consent to a decision for treatment, the patient needs to have the capacity to make the decision, has to have all the relevant information and also the alternatives and material risks. So if a particular treatment has side effects then we have to mention them because, as you gave an example of someone who couldn't travel because they were having lots of diarrhoea and so therefore were worried, say if it's an injection, injections could cause a bit of side effects with diarrhoea. If that patient can't move very quickly and they're on a walking stick with a dodgy hip and can't get to the toilet in time, then that could really impact their lives if they are getting runny stools and have to rush to go to the toilet. So being able to express that, and knowing that, knowing that patient will think that's important for them, we have to be able to give all that relevant information so we can have a shared decision.  

Sally Jenkins  

Yes. That's actually another point I’ve just thought of. It's quite an embarrassing subject and a lot of patients, particularly when they're newly diagnosed, they just don't like mentioning it, “I’ve got to go to the loo a lot”, in a quiet voice. And we notice it a lot at patient meetings. You can tell the old hands, because by the time you've been there half a dozen times, you are discussing your toilet habits and telling funny stories about it and that really does help. But in the beginning, there can be quite a lot of embarrassment and patients just don't want to say anything. So it takes quite a lot of skill from the doctor to make them relaxed and elicit that from them and let them know that, actually it's normal.  

 

Dr Mohid Khan 

Yes, and actually I'm talking about bowels most of my life as a gastroenterologist. I think it's an important point to make and I think there's also a cultural thing, generational differences, etc. Lots of factors that other people are more expert in than myself. So when I moved across from London to Wales I bought a paper questionnaire which was used at a previous institution for other things, not for cancer, and that allowed people just in the waiting room to tick some boxes so that they know how to express themselves if they’re saying things that they might feel embarrassed about. Now we've got digital versions of that and I know that we'll talk about patient outcomes in a moment.  

 

Sally Jenkins 

Yes I can remember that. That's really good. That you can hand the information over without embarrassment and then there's the grounds for discussion. The doctor can open the subject and it's not embarrassing then. 

 

Dr Mohid Khan 

Thanks, Sally. An interesting conversation. So as we come to the end of this, podcast, I'd like to leave the audience with some concluding points. So what do you think the takeaways of our conversation have been?  

 

Sally Jenkins  

From the patient's point of view, what patients want and need is to feel that they are being listened to carefully and their views are being taken into account because what that does is give back a feeling of control, that something like a cancer diagnosis takes away.  

 

Dr Mohid Khan 

And from the clinician perspective, there's communication skills, empathy, the ability to tailor the consultation and information and tailoring shared decision-making to the situation in the patient because people are different. And so I think we've covered quite a lot today. So thank you. Thank you very much, Sally. So, hopefully we'll see you soon! 

 

Tonke de Jong 

If you enjoyed this podcast and want to find out more then please look for the "Oncology Medical Conversation Podcast" under the account of COR2ED Medical Education. Also don’t forget to rate this podcast, subscribe to our channel, and share it with your colleagues. Thank you for listening and see you next time.  

 

This podcast is an initiative of COR2ED and developed by NET CONNECT, a group of international experts working in the field of neuroendocrine tumours. The views expressed are the personal opinions of the experts. They do not necessarily represent the views of the experts' organizations, or the rest of the NET CONNECT group. For expert disclosures on any conflict of interest please visit the COR2ED website. 

After graduating from Imperial College, London, Dr Khan completed higher specialist training in Gastroenterology and Internal Medicine in London including Imperial, University College London, Royal Free and Royal Marsden Hospitals. He was awarded a PhD for his research in NETs whilst at the Royal Free/UCL, achieving numerous publications and national/international awards. After a fellowship in Gastrointestinal consequences of cancer at the Royal Marsden, he moved to Cardiff and was appointed as a Consultant Gastroenterologist in 2014 at Cardiff & Vale University Health Board.  

  

Since 2017, he has successfully led the multi-award-winning transformation of the nationally commissioned Neuroendocrine Cancer service in South Wales. Working through a patient-centred approach, the service has won the UK Patient Experience Network Award and were finalists for BMJ Cancer Team of the Year. It achieved accreditation as a European NET Centre of Excellence in 2022. 

  

Academically, Dr Khan has various Chief and Principal Investigator roles, with research interests in patient outcomes, NETs, service improvement, and real-world data. He has been involved in digital health projects and currently has leadership roles in the digital transformation of healthcare at local and national levels. Through a range of projects and roles with the British Medical Association and Welsh Government, he champions staff wellbeing, equality, diversity and inclusion, in particular, race equality. 

Sally is a semi-retired university lecturer living in South Wales. Since being diagnosed with a neuroendocrine tumour in 2009, Sally has experienced many consultations with different clinicians over the years. Sally believes it is anabsolute necessity for all NET patients to have access to a specialist NET service. She also feels patient support is crucial for patients living with NETs andhas been involved in patient groups and advocacy for many years. 

Listen and follow our podcasts on:

Ipsen

In this discussion, the experts share their own views and experiences on the treatment options available. Conversation topics include:

  • Pros and cons of different treatment settings, including home vs hospital-based injections
  • The importance of individualising treatment decisions
  • Studies reporting patient preferences and how the data can be used to inform patient decisions

 

Clinical takeaways

  • Considering patient perspectives enables patients with NETs to feel listened to, more relaxed, and in control
  • Shared decision-making in NET management allows for tailored consultations based on individual patient preferences and needs
  • Evidence suggests that patients with NETs prefer treatment injections at home to hospital visits

Educational objectives

  • Highlight the value of shared decision-making in NET management

NET Shared Decision Making  

Optimising physician and patient consultations 

Episode 2: Individualising Treatment Decisions 

 

Brought to you by 

Dr Mohid S. Khan, Consultant in Gastroenterology & NETs, Clinical Lead, South Wales NET Service, University Hospital of Wales 

Sally Jenkins, NET Patient and Patient Advocate 

 

Please note: 

NET CONNECT podcasts are designed to be listened to. If possible, we encourage you to listen to the audio or watch the video, which includes emotion and emphasis that cannot be portrayed in the transcript. Transcripts are edited for readability. Please check the corresponding audio before quoting in print. 

 

This podcast is supported by an independent educational grant from Ipsen.  

 

Dr Mohid Khan 

Welcome to our podcast, where we're going to talk about shared decision-making in neuroendocrine tumours, or NETs, how to individualise patient treatment and factors associated with that. I’m Dr Mohid Khan. I'm a Consultant Gastroenterologist and lead at the Neuroendocrine Tumour Service, South Wales, UK, and this is Sally. 

 

Sally Jenkins 

Hello, I'm Sally Jenkins. I'm a NET patient of 15 years standing. It’s made a great difference to my life, but it’s now stable and I live a very good life.  

 

Dr Mohid Khan 

So if we get onto the shared decision-making examples. Going back, you have the injection, the somatostatin analogue injections every month. And initially, you had to come to the hospital and there was no choice. But then after services developed, there is the home care service. So that injection can be delivered at home and a nurse comes out to inject, and in some cases, with some drugs, in some countries where the injection, or giving the injection, could be taught, so the patient learns how to give it themselves or a carer or relative could learn. And, I guess in the beginning, when you're having to come to the hospital, parking is always a major issue in UK hospitals, but a disadvantage of just having it at home is that you'd miss the social aspect, in seeing a nurse, seeing other patients. So it's important, I guess, that if we have home care services, that patient support, nurse helpline, ability for patients to have groups is really important. 

 

Sally Jenkins  

Yes. That’s what happened to me. When I was coming into the hospital, there wasn't a nurse helpline and there wasn't a particularly extensive patient support group, so coming into the hospital was important because I could talk over the previous month with the CNS (Clinical Nurse Specialist), I also bumped into other patients. But then as the service was set up and things matured, then home care was better because there was a nurse helpline and also there was a well-established patient support group. So I was getting what I needed in that direction elsewhere, not from the hospital. That's when, you know, going home, being able to have it done at home, became much more advantageous. And I think it is for a lot of people actually. As long as you've got the other support, because it can be very isolating. 

One thing about the nurses who delivered the injections is that they are very good at doing that type of injection, but they are not NET specialists and they don't really know what the injection does in detail. And so you can't actually discuss with them the sort of things that you can discuss with your NET CNS (Clinical Nurse Specialist) or other patients. 

 

Dr Mohid Khan 

And so it is important to have that ability to interact with the NET service, even if these injections are given at home or given around the country, if someone's travelling and, people travel around the country and Europe and, come back and so it gives that flexibility.  

 

Sally Jenkins  

Yes. Again, this is very individual. Because some people want to go off travelling. Others, different ages maybe, different stages in life, they want to stay home.  

 

Dr Mohid Khan 

And we see that. So some people, you know, do want some sort of routine and want to come to an institution or a practice in primary care with their GP. Obviously there are resource implications. But it is important to be, I think, giving choices to patients.  

 

Sally Jenkins  

Yes. We're coming back to shared decision-making here again. And again, that gives you a feeling of control as a patient because one thing that the cancer diagnosis does do, or any serious illness diagnosis does to a patient psychologically, is it kicks the bucket of certainty out from under your feet entirely. And I don't know if anybody's ever really got it back afterwards. And NETs are very uncertain.  

 

Dr Mohid Khan 

Yes. I think it's that uncertainty that we have to communicate. Similar to that, there's no right or wrong answer, right or wrong treatment. I think that there's a need to communicate that uncertainty.  

 

Sally Jenkins  

That's really important, because I've heard, and a lot of patients have said to me, ‘Oh, people say to me, oh, you can't be seriously ill because you've still got your hair and you don't have chemo, so, you know, you can't have serious cancer’. Actually, you do but it's just a different type of cancer. And so, because it's such a long-term condition, whereas as I said, you've got to reconstruct your new normality, then you need that feeling of some control and need some feeling of choice that you can steer your own ship. You can, you know, have your own destiny.  

 

Dr Mohid Khan 

That patient, going to the toilet and couldn’t travel, that reminds me of one of the very first patients I saw on moving. I remember her being in tears when I moved to South Wales because she had some bowel issues and just had to use public transport in a geographical area, which she couldn't drive and had to get to family and was worried about getting onto the bus and it was that uncertainty that I felt from her. But I guess the goals with the shared decision-making is trying to figure out where you can get to, and having some certainty of having that uncertainty if that makes sense, that living.  

 

Sally Jenkins  

Yes, I suppose it's a controlled uncertainty, if you know what I mean. There are some things that you can rely on and the rest of it, you just have to go with the flow. But the certainties, the things that you can rely on are psychologically very good for you, for the patient, it means that you can actually think, yes, I can cope with this. I can do it.  

Dr Mohid Khan 

And I guess, we have a cancer psychologist, so, they run courses on managing uncertainty or living with uncertainty as well, they put on the patient groups and patients, which, I guess it all boils down to having that shared decision-making process and then, coming back to it. But I guess we were talking about injections, so bringing it back to the injections. Obviously some injections, some people can be taught to self-inject and some can't. So there's a study, PREF-NET, that was looking at particular somatostatin analogue injections and comparing having an injection in hospital versus having it at home. 

 

And there were some questionnaires to complete but also some qualitative interviews. So just freestyle interview and then some clever people who, not me, were analysing that data and out of the study there were quite stark results: 99% of patients preferred to have their injection at home. I mean, you can probably guess the sorts of things that they quoted and how it helped them. ‘What advantages does having a home injection have?’ I mean, we've talked about flexibility, is there anything else that you think would be an advantage of having an injection at home, have you had that experience?  

 

Sally Jenkins  

I think one of the advantages, again, it's psychological, in that you become less medicalised, if I can use that word. If you have to go into a hospital or even to a GP surgery every month, that says, ‘Patient, a person who is ill’. If it's something that you can do at home, it’s easier. You can carry on with your normal routine. You know, it only takes half an hour out of your day and it's not a problem. But it's also not pointing out that you are a cancer patient. Because again, that's the psychology of it. It's the way that people regard themselves and if you regard yourself as an ill person all the time and you're having all these reminders, and we have enough reminders of that, you know, okay, my bowels are not normal, I have to go to the loo more frequently than other people do. So I get those daily reminders. I don't need the additional one that, ‘oh yes, next Wednesday I've got to take the morning out to make sure I go to the hospital’. That psychologically makes a lot of difference as well as the practical aspect. 

 

Dr Mohid Khan 

You're right. I think out of that study, one of the findings through the interviews was that it did give patients confidence, and quality of life was improved if they can have the injection at home, out of hospital. And, more psychologically, more comfort. With that study, the PREF-NET study, as well as the local psychological impact in a positive way, they’re more confident in managing themselves.  

So it's the practical stuff, the cost of going to a hospital and also the cost of taking time out. And if it's someone working then, you know, I know, sort of, my own story and my family's story, where you have to coordinate and who's going to look after, who's doing the pick-up, is work going to allow lots of appointments? And therefore… and if someone's self-employed, so self-employed people they don't have that sick-pay because they work for themselves. And that's something also which came out of that study. As well as the practical thing about getting to hospital. 

 

Sally Jenkins  

Yes, it can get expensive 

 

Dr Mohid Khan 

It can, and obviously there are concessions in various hospitals, in most hospitals, especially if you've got cancer. But just having that anxiety if they're driving, worrying about getting there on time and missing their injection and finding a parking space, was something that obviously came out. 

 

 

Sally Jenkins  

Yes. It's funny, a number of patients say, ‘oh, when I have those injections, they make me tired’. I don't actually believe that. I rather think it's the stress of having to get there or whatever makes you tired. Whereas it's not a physical side effect. It's a psychological side effect. And some people say, ‘oh, I get a dreadful ache in my leg’. Well, you can, but not necessarily and I think a lot of that is psychological rather than physical.  

 

Dr Mohid Khan 

Yes, and I think anxiety does make you tired and, you know, and everyone knows you tense up and you get stressed, and the mental activity and concentration, and then sort of having that adrenaline rush and then it goes and then you get that afterwards, the adrenaline sort of seeps out, and then you have that down and you feel tired. And you're right. It could be that, I don't know for sure.  

The studies with the injections and neuroendocrine tumours such as PREF-NET, there's sort of systematic reviews of summaries of studies. David Cella’s,  where they looked at a number of different papers which also reported some of this preference for particular injections and the preference for self-injection. Obviously injections, if you get into technicalities, some of them are prefilled, so it's a syringe, it's ready-made. And some have to be made up and there’s some solutions to make up, and then, you know, relying on a nurse to do it in the right way and they have to be reasonably experienced. So there's these other factors. But certainly some studies have looked at, the simple thing, the simple injections where it's all ready-made, there’s more confidence generally in giving it.  

 

Sally Jenkins  

Well, again, we're coming back to control and confidence all the time aren’t we? 

 

Dr Mohid Khan 

Yes, yes.  

 

Sally Jenkins  

And that's what good shared decision-making does.  

 

Dr Mohid Khan 

And I guess these are studies, similar studies and there's ongoing studies with patient-reported outcomes. In the real-world, PCORNET, looking at patient-reported outcome measures, responses to treatments and all sorts of settings. Patient-reported outcomes are essentially what you talked about towards the beginning of our conversation – questionnaires essentially. ‘How do you feel on a scale of 1-5, 1- 4? Bowels, various symptoms and quality of life’. They’re coming on board in real life in clinical practice. ‘How do you feel about them in just real life, fitting them in?’ and does it give you any information for yourself? 

 

Sally Jenkins 

It does actually. It makes you focus on how you are, which is good. It doesn't take very long now that we can do them online. It's quite easy. It becomes part of the routine, and I think it's useful because I do tend to look back when I get a little reminder to fill in my ‘How are You’ questionnaire. And I will look back over the previous few months and I think, ‘Oh yes, I'm doing better than I was’ or ‘I had a dip then’ it's quite useful to know yourself.  

And when, sorry a slight sideline, when they were first introduced, I think, right at the very beginning, when you arrived, you were doing some data collection and you used it in a study, and I think it got as far as a poster at one of the conferences. Well we had a patient support group at that time. And when it came back that there was that poster and that was us, at one of those groups we had the poster and I said, ‘Look, that's us. Somebody has taken notice of us, and this group’. It really gave a boost to morale because we were all feeling a little bit ignored at the time. Because, as I said, we didn't have a dedicated service then, one has come now, but at that time, it was a really good psychological effect. So I think you get a group psychological effect as well as an individual one with that sort of thing. And then of course, if people aren't interested in statistics, well, then they don't have to look at them. 

 

Dr Mohid Khan 

I guess not. And on the individual level those questionnaires, patient outcome measures, it’s helpful because it does allow the consultation to be tailored in a set when you can say, ‘well, that thing there, that's important for the patient’. They’ve gone off the scale so let's explore that in detail. 

 

Sally Jenkins 

Is there also, like exception reporting? Don't some of the CNS’s (Clinical Nurse Specialist) keep an eye on it? And if somebody is really dipping, they are well aware that somebody’s having a bad time? 

 

Dr Mohid Khan 

On paper, it’s obviously done in the waiting room, but digitally we've got systems now which are coming into real life, which in the real world which could help those shared decision-making processes. And I guess it’s going back to those shared decision-making processes in the real world. I mean, how do these studies matter? Or do they inform what you think is important to patients?  

 

Sally Jenkins 

Well, yes, of course they matter. I mean, I have been a numbers person and quite often if somebody makes an assertion, I say, “Well, where's the research to back it up?” Because that is important. I mean, that tells you whether it's opinion or whether it is fact, as we see it, whether the numbers support it. I mean, there's always the interpretation, but if you haven't got the data, then you can't have interpretation. And I know that a lot of choices, particularly in the NHS, are made on research.  

 

Dr Mohid Khan 

And on evidence. 

 

Sally Jenkins 

Yes, on evidence, it’s evidence based, you've got to have it. So I think some people understand the, you know, the necessity for it.  

 

Dr Mohid Khan 

Yes. And I think that's important because some of these studies didn't exist five, six, seven years ago. And clearly these have shown now that there are a number of factors in patients’ experience that, as well as patient outcomes, are important in this decision-making process when it comes to these treatments. 

 

Dr Mohid Khan 

Thanks, Sally. An interesting conversation. So as we come to the end of this podcast, I'd like to leave the audience with some concluding points. So what do you think the takeaways of our conversation have been?  

 

Sally Jenkins  

From the patient's point of view, what patients want and need, I feel, is to feel that they are being listened to carefully and their views are being taken into account because what that does is give back a feeling of control, that something like a cancer diagnosis takes away.  

 

Dr Mohid Khan 

And from the clinician perspective, there's communication skills, empathy, the ability to tailor the consultation and information and tailoring shared decision-making to the situation in the patient because people are different. When it comes to the injections and the choice in certain areas over injections. Taking into consideration those other factors we talked about in terms of listening to the patients and how that would impact them in terms of the side effects or how it affects their life in terms of flexibility, travel, etc.  

 

And so I think we've covered quite a lot today. So thank you. Thank you very much, Sally. So, hopefully we'll see you soon! 

 

Tonke de Jong 

If you enjoyed this podcast and want to find out more then please look for the "Oncology Medical Conversation Podcast" under the account of COR2ED medical education. Also don’t forget to rate this podcast, subscribe to our channel and share it with your colleagues. Thank you for listening and see you next time. 

 

This podcast is an initiative of COR2ED and developed by NET CONNECT, a group of international experts working in the field of neuroendocrine tumours. The views expressed are the personal opinions of the experts. They do not necessarily represent the views of the experts' organizations, or the rest of the NET CONNECT group. For expert disclosures on any conflict of interest please visit the COR2ED website. 

After graduating from Imperial College, London, Dr Khan completed higher specialist training in Gastroenterology and Internal Medicine in London including Imperial, University College London, Royal Free and Royal Marsden Hospitals. He was awarded a PhD for his research in NETs whilst at the Royal Free/UCL, achieving numerous publications and national/international awards. After a fellowship in Gastrointestinal consequences of cancer at the Royal Marsden, he moved to Cardiff and was appointed as a Consultant Gastroenterologist in 2014 at Cardiff & Vale University Health Board.  

  

Since 2017, he has successfully led the multi-award-winning transformation of the nationally commissioned Neuroendocrine Cancer service in South Wales. Working through a patient-centred approach, the service has won the UK Patient Experience Network Award and were finalists for BMJ Cancer Team of the Year. It achieved accreditation as a European NET Centre of Excellence in 2022. 

  

Academically, Dr Khan has various Chief and Principal Investigator roles, with research interests in patient outcomes, NETs, service improvement, and real-world data. He has been involved in digital health projects and currently has leadership roles in the digital transformation of healthcare at local and national levels. Through a range of projects and roles with the British Medical Association and Welsh Government, he champions staff wellbeing, equality, diversity and inclusion, in particular, race equality. 

Sally is a semi-retired university lecturer living in South Wales. Since being diagnosed with a neuroendocrine tumour in 2009, Sally has experienced many consultations with different clinicians over the years. Sally believes it is anabsolute necessity for all NET patients to have access to a specialist NET service. She also feels patient support is crucial for patients living with NETs andhas been involved in patient groups and advocacy for many years. 

Programme summary
Listen to the podcast now
Share this programme
This educational programme is supported by an Independent Educational Grant from Ipsen
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Ipsen
Endorsement
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
NET CONNECT

NET CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Ipsen and from Eisai Europe Limited.

Meet the experts Independent IME approved
Programme summary
Listen to the podcast now
Share this programme
This educational programme is supported by an Independent Educational Grant from Ipsen
Supporter Acknowledgement
This educational programme is supported by an Independent Educational Grant from Ipsen
Endorsement
I agree that this educational programme:

Was valuable to me

1/4
Brought to you by
NET CONNECT

NET CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Ipsen and from Eisai Europe Limited.

Meet the experts Independent IME approved

Other programmes of interest

podcast Podcast
Oncology 
HR+/HER2- metastatic breast cancer: Best practices in molecular testing and targeted therapy

Optimising precision medicine for improved patient outcomes

Experts
Dr Roberto Salgado, Assoc. Clinical Professor Rena Callahan
Endorsed by
ICAN international cancer advocacy network ISLB Exon20group
Biomarker Collaborative
  • download Downloadable
    Resources
  • clock 26 MIN
  • calendar Mar 2025

Educational programme supported by an Independent Educational Grant from Thermo Fisher Scientific.
conference-update Conference update
Oncology 
Current and future treatment strategies for patients with ER+/HER2- early breast cancer

A closer look at the evolving treatment landscape

Experts
Prof. Michael Gnant, Prof. Giuseppe Curigliano
  • download Downloadable
    Resources
  • clock 4 MIN
  • calendar Mar 2025

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only.
video Video
Oncology 
LEAP-012 publication snapshot

Expert insights on multimodal treatment for intermediate hepatocellular carcinoma (HCC)

Experts
Prof. Arndt Vogel
Endorsed by
DiCE Global Liver Institute Blue Faery plus
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Mar 2025

This programme has been sponsored by Eisai Europe Limited ("Eisai"). Eisai has had no input on the educational content of, or speakers involved in this programme.
conference-update Conference update
Oncology 
ER+ metastatic breast cancer: Highlights from the 13th APBCS Satellite Symposium

Medical experts discuss treatment strategies and sequencing after ET + CDK4/6i for ER+/HER2- metastatic breast cancer  

Experts
Prof. Shaheenah Dawood, Prof. Heather McArthur, Prof. Javier Cortés, Prof. Frédérique Penault-Llorca
  • download Downloadable
    Resources
  • clock 5 MIN
  • calendar Feb 2025

This programme has been sponsored by Menarini Stemline and is intended for healthcare professionals only.
podcast Podcast
Hemostasis and bleeding disorders Oncology 
Σειρά podcast για τη διαχείριση της θρόμβωσης

Αναλύσεις από καταξιωμένους ειδικούς ιατρούς. Πλοηγηθείτε στις καρτέλες για να επιλέξετε ένα επεισόδιο podcast

Experts
Prof. Dimitrios Tsakiris, Prof. Michael Nagler, Dr Lars Asmis, Prof. Jerzy Windyga
  • download Downloadable
    Resources
  • clock 27 MIN
  • calendar Feb 2025

This educational programme is supported by an Independent Educational Grant from Viatris.
conference-update Conference update
Oncology 
ESMO Virtual Plenary: Final OS results from the phase III TROPION-Breast01 trial

How will the latest Dato-DXd data impact treatment strategies for HR+/HER2− mBC?

Experts
Prof. François-Clément Bidard, Dr Barbara Pistilli
  • clock 5 MIN
  • calendar Feb 2025

Educational programme supported by an Independent Educational Grant from AstraZeneca